130 related articles for article (PubMed ID: 16001164)
21. Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas.
Parney IF; Chang LJ; Farr-Jones MA; Hao C; Smylie M; Petruk KC
J Neurooncol; 2006 May; 78(1):71-80. PubMed ID: 16718522
[TBL] [Abstract][Full Text] [Related]
22. Induction of anti-tumor immunity by lyophilized myeloma cells secreting GM-CSF.
Wu S; Yuan D; Liu JN; Tan XY
Oncol Rep; 2007 Jan; 17(1):129-33. PubMed ID: 17143489
[TBL] [Abstract][Full Text] [Related]
23. [Lethal effect of cytotoxic lymphocytes against U266 cells induced by DCs modified with GM-CSF gene and pulsed with tumour antigen].
Li CT; Zhu XP; Xu WQ; Xiao HF; Dong ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):929-32. PubMed ID: 19698231
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus-mediated delivery of p53 results in substantial apoptosis to myeloma cells and is not cytotoxic to flow-sorted CD34(+) hematopoietic progenitor cells and normal lymphocytes.
Liu Q; Gazitt Y
Exp Hematol; 2000 Dec; 28(12):1354-62. PubMed ID: 11146157
[TBL] [Abstract][Full Text] [Related]
25. Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines.
Inoue H; Iga M; Nabeta H; Yokoo T; Suehiro Y; Okano S; Inoue M; Kinoh H; Katagiri T; Takayama K; Yonemitsu Y; Hasegawa M; Nakamura Y; Nakanishi Y; Tani K
Cancer Sci; 2008 Nov; 99(11):2315-26. PubMed ID: 18957055
[TBL] [Abstract][Full Text] [Related]
26. Gene therapy with B7.1 and GM-CSF vaccines in a murine AML model.
Dunussi-Joannopoulos K; Weinstein HJ; Arceci RJ; Croop JM
J Pediatr Hematol Oncol; 1997; 19(6):536-40. PubMed ID: 9407942
[TBL] [Abstract][Full Text] [Related]
27. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
28. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
Tai KF; Chen PJ; Chen DS; Hwang LH
J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087
[TBL] [Abstract][Full Text] [Related]
29. Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene.
Kusumoto M; Umeda S; Ikubo A; Aoki Y; Tawfik O; Oben R; Williamson S; Jewell W; Suzuki T
Cancer Immunol Immunother; 2001 Sep; 50(7):373-81. PubMed ID: 11676397
[TBL] [Abstract][Full Text] [Related]
30. Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects.
Tian H; Shi G; Yang G; Zhang J; Li Y; Du T; Wang J; Xu F; Cheng L; Zhang X; Dai L; Chen X; Zhang S; Yang Y; Yu D; Wei Y; Deng H
BMC Cancer; 2014 Jan; 14():48. PubMed ID: 24475975
[TBL] [Abstract][Full Text] [Related]
31. Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7-1.
Büeler H; Mulligan RC
Mol Med; 1996 Sep; 2(5):545-55. PubMed ID: 8898371
[TBL] [Abstract][Full Text] [Related]
32. Improved therapeutic outcome following combination immunogene vaccination therapy in murine myeloma.
Li ZH; Wen XY; Mandelbaum S; Falcioni N; Hawley TS; Hawley RG; Stewart AK
Leuk Lymphoma; 2003 Oct; 44(10):1775-84. PubMed ID: 14692533
[TBL] [Abstract][Full Text] [Related]
33. [GM-CSF gene-modified dendritic cell vaccine enhances antitumor immunity in vitro].
He SB; Sun K; Wang L; Li DC; Zhang YY
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):410-4. PubMed ID: 20819479
[TBL] [Abstract][Full Text] [Related]
34. Human brain tumor cell culture characterization after immunostimulatory gene transfer.
Parney IF; Farr-Jones MA; Koshal A; Chang LJ; Petruk KC
Neurosurgery; 2002 May; 50(5):1094-102. PubMed ID: 11950413
[TBL] [Abstract][Full Text] [Related]
35. Irradiated tumor cells adenovirally engineered to secrete granulocyte/macrophage-colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice.
Nagai E; Ogawa T; Kielian T; Ikubo A; Suzuki T
Cancer Immunol Immunother; 1998 Oct; 47(2):72-80. PubMed ID: 9769115
[TBL] [Abstract][Full Text] [Related]
36. Production of granulocyte-macrophage colony-stimulating factor by T cells is regulated by B7 and IL-1 beta.
Kruger M; Van Gool S; Peng XH; Coorevits L; Casteels-Van Daele M; Ceuppens JL
Immunology; 1996 May; 88(1):49-54. PubMed ID: 8707349
[TBL] [Abstract][Full Text] [Related]
37. Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity.
Tenbusch M; Kuate S; Tippler B; Gerlach N; Schimmer S; Dittmer U; Uberla K
BMC Immunol; 2008 Apr; 9():13. PubMed ID: 18405363
[TBL] [Abstract][Full Text] [Related]
38. Combination of p53-DC vaccine and rAd-p53 gene therapy induced CTLs cytotoxic against p53-deleted human prostate cancer cells in vitro.
Saito H; Kitagawa K; Yoneda T; Fukui Y; Fujsawa M; Bautista D; Shirakawa T
Cancer Gene Ther; 2017 Jul; 24(7):289-296. PubMed ID: 28621316
[TBL] [Abstract][Full Text] [Related]
39. Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine.
Chang EY; Chen CH; Ji H; Wang TL; Hung K; Lee BP; Huang AY; Kurman RJ; Pardoll DM; Wu T
Int J Cancer; 2000 Jun; 86(5):725-30. PubMed ID: 10797297
[TBL] [Abstract][Full Text] [Related]
40. Anti-gastric cancer active immunity induced by FasL/B7-1 gene-modified tumor cells.
Zheng SY; Li DC; Zhang ZD; Zhao J; Ge JF
World J Gastroenterol; 2005 Jun; 11(21):3204-11. PubMed ID: 15929168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
